JPMorgan Chase & Co. Sells 3,395 Shares of Capital Group Core Plus Income ETF (NYSEARCA:CGCP)
JPMorgan Chase & Co. cut its holdings in shares of Capital Group Core Plus Income ETF (NYSEARCA:CGCP – Free Report) by 7.1% ...
Upstream16h
What Venture Global’s IPO means for its founders' net worth — and for the company
Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...
Tuttle Capital seeks SEC approval for leveraged ETFs tied to crypto tokens including $TRUMP
Tuttle Capital Management is seeking approval to launch 10 new leveraged exchange-traded funds tied to a wide array of cryptocurrencies that include the just-launched $TRUMP and $MELANIA tokens, ...
Forbes2d
Favorable Capital Gains Signaled For U.S. Crypto
Wrapping up a bullish week for cryptocurrency development in the U.S., Eric Trump released a statement confirming exemptions from capital ... the U.S. Securities and Exchange Commission (SEC).
Davis Capital Management Cuts Position in Alphabet Inc. (NASDAQ:GOOGL)
Davis Capital Management cut its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 6.4% during the fourth quarter, ...
SEC revokes unpopular banking rule that blocked Wall Street banks from adopting crypto
After years of lobbying by the crypto industry, the U.S. Securities and Exchange Commission has rescinded an accounting rule ...
McMaster calls for teacher pay raises, tax cuts, endorses restarting V.C. Summer project in State of the State address
Education was a central theme, with McMaster proposing an increase in minimum starting teacher salaries to $50,000—a 56.1% ...
etf.com Announces Nominees for 2025 Awards
Awards nominees. etf.com is pleased to announce the short list of nominations for the 2025 etf.com Awards. These funds, ...
Wall Street asks SEC to extend timeline for US Treasury market overhaul
Wall Street is asking regulators for more time to implement a rule requiring centralized Treasury clearing as banks and funds ...
Obesity drug developer Aardvark files for IPO
Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't ...
Business Insider6d
Revance Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 29, 2024 ...